New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

FLAMINGO-01 Annual Patient Screen Rate Increases to Over 800 Patients per Year Over the past 6 months, the Company achieved its highest screening rate of approximately 200 patients per quarter or the ...

Ten years ago, a discussion in Milan set a demanding project in motion. In a meeting between a biologist and a urologist, one question kept ...

Moffit Cancer Center researchers found four "protein EpiScores" that were associated with disease-free survival, one of which was also associated with overall survival.

Phase III study will be "sufficient and pivotal for registration in the U.S." Kiniksa Pharmaceuticals ( KNSA 2.70%) ...

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery comp ...

Since 2023, Kim Jong Un and Kim Yo Jong have repeatedly labeled South Korea as an " enemy state," solidifying the language that turns inter-Korean relations into a state-to-state, rather than ...

Brad Setser is the Whitney Shepardson senior fellow at the Council on Foreign Relations. This Ukraine Policy Brief is part of the Council Special Initiative on Securing Ukraine’s Future and the ...